The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
The latest report by IMARC, titled “ PharmaceuticalRobotsMarket:GlobalIndustryTrends,Share,Size,Growth,OpportunityandForecas t2023-2028
”findsthattheglobal pharmaceuticalrobotsmarketsizereachedUS$180.1Millionin2022.
Pharmaceutical robots are physically embodied artificial intelligence (AI) agents designed to perform routine tasks, eliminating the need for human intervention. They help automate various functions, including inspection, packaging, dispensing, drug sorting, kit assembly,and light machine-tending. They also aid in the production of customized medicines, reducing workloads, and preventing drug contamination.
Besides this, they assist in improving productivity, ensuring consistency, minimizing downtime, enhancing flexibility, and speeding up processes. As a result, pharmaceutical robots are gaining immense traction across the pharmaceutical industry as they offer maximum efficiency, protect workersfromhazardousenvironments,andcutcosts.
Request Free Sample Report: https://www.imarcgroup.com/pharmaceutical-robots-market/requestsample
The surging need for automation in manufacturing units represents the primary factor driving the market growth. Moreover, the significant expansion in the pharmaceutical sector and the increasing competition have prompted drug manufacturers to adopt pharmaceutical robots as they enhance safety, reliability, and financial savings. Along with this, the high costs of new drug discovery have augmented the demand for robots in clinical trials, drug discovery, and laboratories for automating procedures. Besides this, the rising preferences for personalized medicine that requires customized medications, packaging, and labeling have accelerated product adoption rates. Additionally, there has been a substantial increase in the demand for specific packaging configurations and other benefits, such as high speed, precision, optimal utilization of space, and zero error operations. In line with this, various technological advancements, such as the integration of artificial intelligence (AI) in robotics, have catalyzed market growth. Furthermore, the leading players are engaging in research and development (R&D) activities to launch collaborative robots. Apart from this, due to rising drug discovery and diagnostic testing, the emerging laboratory applications of pharmaceutical robots like vial handling to minimize the risks of human contamination have propelled market growth. Other factors, including the surging product adoption in quality control and inspection of pharmaceutical drugs, lack of skilled labor, and increasing merger and acquisition (M&A) activities among key players, are also creating a favorable market outlook. Looking forward, IMARC Group expects the market value to reach US$ 327.9 Million by 2028, growing at a CAGR of 10.2% during 2023-2028.
Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).
MarketSummary:
BreakupbyType:
•Traditional Robots
•ArticulatedRobots
•SCARARobots
•Delta/ParallelRobots
•CartesianRobots
•Dual-armRobots
•CollaborativePharmaceuticalRobots
BreakupbyApplication:
•PickingandPackaging
•InspectionofPharmaceuticalDrugs
•LaboratoryApplications
BreakupbyEndUser:
•PharmaceuticalCompanies
•ResearchLaboratories
BreakupbyRegion:
•NorthAmerica
•UnitedStates
•Canada
•Asia-Pacific
•China
•Japan
•India
•SouthKorea
•Australia
•Indonesia
•Others
•Europe
•Germany
•France
•UnitedKingdom
•Italy
•Spain
•Russia
CompetitiveLandscapewithKeyPlayers:
• ABBLtd
• DENSOCorporation
• FANUCCorporation
• KawasakiHeavyIndustriesLtd.
• KukaAG
• Marchesini GroupS.p.A
• MitsubishiElectricCorporation
• RobertBoschGmbH
• SeikoEpsonCorporation
• ShibuyaCorporation
• UniversalRobotsA/S(TeradyneInc.)
• YaskawaElectricCorporation.
ViewFullReportwithTOC&ListofFigure:
https://www.imarcgroup.com/pharmaceutical-robots-market
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
